Wockhardt gets USFDA warning over Waluj plant

Sep 28 2013, 19:49 IST
Comments 0
SummaryQuality check: Warning to Wockhardt comes for not meeting manufacturing norms

to be in the range of $100 million

*Earlier this month, the UK regulator barred the company from producing drugs for Europe from the same plant

*The US is Wockhardt’s biggest market and fetched the company $531 million in revenues in FY’13

*he warning could hit sales from the Waluj plant by 9%

Single Page Format
Ads by Google

More from Companies

Reader´s Comments
| Post a Comment
Please Wait while comments are loading...